Switzerland Pharmaceuticals

Cosmo Pharmaceuticals NV (COPN)

Track

Cosmo Pharmaceuticals NV recorded no insider trading activity during the past three months. The most recent transactions occurred in May 2026, consisting exclusively of share sales. Prior to this period, historical data indicates a mix of divestments and a single purchase recorded in March 2026.
Ticker: COPN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cosmo Pharmaceuticals NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 11 May 2026
Value CHF577,395.90 | Price 469.83 | Shares 28,802
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-11 S Sale Non-Executive Director
28,802
469.83
CHF577,396 		28,802 469.83 CHF577,396
2026-05-04 2026-05-04 S Sale Non-Executive Director
53,872
129.79
CHF4,252,740 		53,872 129.79 CHF4,252,740
2026-05-04 2026-05-04 S Sale Non-Executive Director
92,613
114.70
CHF2,437,987 		92,613 114.70 CHF2,437,987
2026-04-21 2026-04-21 S Sale Non-Executive Director
4,000
99.00
CHF396,000 		4,000 99.00 CHF396,000
2026-04-20 2026-04-20 S Sale Non-Executive Director
10,500
98.78
CHF1,037,148 		10,500 98.78 CHF1,037,148
2026-04-17 2026-04-17 S Sale Non-Executive Director
7,500
97.93
CHF734,497 		7,500 97.93 CHF734,497
2026-04-16 2026-04-16 S Sale Non-Executive Director
8,500
98.36
CHF836,102 		8,500 98.36 CHF836,102
2026-04-15 2026-04-15 S Sale Non-Executive Director
30,050
102.58
CHF3,082,529 		30,050 102.58 CHF3,082,529
2026-03-09 2026-03-09 B Purchase Non-Executive Director
2,886
92.00
CHF265,512 		2,886 92.00 CHF265,512
2026-01-21 2026-01-21 S Sale Executive Director / Officer
1,000
114.00
CHF114,000 		1,000 114.00 CHF114,000
2026-01-16 2026-01-16 S Sale Executive Director / Officer
2,000
109.80
CHF219,600 		2,000 109.80 CHF219,600
2026-01-16 2026-01-16 S Sale Executive Director / Officer
1,000
110.50
CHF110,500 		1,000 110.50 CHF110,500
2026-01-16 2026-01-16 S Sale Executive Director / Officer
100
110.40
CHF11,040 		100 110.40 CHF11,040
2026-01-15 2026-01-15 S Sale Executive Director / Officer
1,000
107.20
CHF107,200 		1,000 107.20 CHF107,200
2026-01-14 2026-01-14 S Sale Executive Director / Officer
500
107.00
CHF53,500 		500 107.00 CHF53,500
2026-01-14 2026-01-14 S Sale Executive Director / Officer
500
106.40
CHF53,200 		500 106.40 CHF53,200
2026-01-13 2026-01-13 S Sale Executive Director / Officer
1,000
107.00
CHF107,000 		1,000 107.00 CHF107,000
2026-01-07 2026-01-07 S Sale Executive Director / Officer
1,000
108.50
CHF108,500 		1,000 108.50 CHF108,500
2026-01-06 2026-01-06 S Sale Executive Director / Officer
1,000
108.30
CHF108,300 		1,000 108.30 CHF108,300
2026-01-05 2026-01-05 S Sale Executive Director / Officer
155
107.00
CHF16,585 		155 107.00 CHF16,585
Explore more

More insider trading research around Cosmo Pharmaceuticals NV

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index